Cargando…

Healthcare Professionals’ Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease

BACKGROUND: Registration authorities evaluate effects of new medicines for chronic obstructive pulmonary disease (COPD) on airway obstruction, dyspnea, health status and exacerbations. To establish clinical relevance, minimal clinically important differences (MCIDs) are used. The aim of this study w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dankers, Marloes, Nelissen-Vrancken, Marjorie H. J. M. G., Surminski, Sara M. K., Lambooij, Anke C., Schermer, Tjard R., van Dijk, Liset
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016298/ https://www.ncbi.nlm.nih.gov/pubmed/32116657 http://dx.doi.org/10.3389/fphar.2019.01519

Ejemplares similares

Alignment between outcomes and minimal clinically important differences in the Dutch type 2 diabetes mellitus guideline and healthcare professionals’ preferences
por: Dankers, Marloes, et al.
Publicado: (2021)

Newer long-acting insulin prescriptions for patients with type 2 diabetes: prevalence and practice variation in a retrospective cohort study
por: Dankers, Marloes, et al.
Publicado: (2022)

Marketing of medicines in primary care: An analysis of direct marketing mailings and advertisements
por: Dankers, Marloes, et al.
Publicado: (2023)

Commentary: “Healthcare Professionals’ Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease” by Dankers M et al. in Frontiers in Pharmacology 2020; 10: 1519
por: Alma, Harma, et al.
Publicado: (2020)

Use of Opioids Increases With Age in Older Adults: An Observational Study (2005–2017)
por: Weesie, Yvette M., et al.
Publicado: (2020)

Minimal clinically important difference for asthma endpoints: an expert consensus report
por: Bonini, Matteo, et al.
Publicado: (2020)

Guideline Adherence in Antibiotic Prescribing to Patients with Respiratory Diseases in Primary Care: Prevalence and Practice Variation
por: Hek, Karin, et al.
Publicado: (2020)

Pharmacist-Led Self-management Interventions to Improve Diabetes Outcomes. A Systematic Literature Review and Meta-Analysis
por: van Eikenhorst, Linda, et al.
Publicado: (2017)

The importance of reminders and patient preferences to improve inhaler technique in older adults with COPD
por: Barnestein-Fonseca, P., et al.
Publicado: (2023)

Shared decision making and medication adherence in patients with COPD and/or asthma: the ANANAS study
por: Achterbosch, Maria, et al.
Publicado: (2023)

The Global Lung Function Initiative 2012 Equations Are as Well-Suited as Local Population Derived Equations to a Sample of Healthy Professional Firefighters
por: Slattery, Flynn, et al.
Publicado: (2017)

Important adverse events to be evaluated in antidepressant trials and meta-analyses in depression: a large international preference study including patients and healthcare professionals
por: Chevance, Astrid, et al.
Publicado: (2022)

Are component endpoints equal? A preference study into the practice of composite endpoints in clinical trials
por: Vaanholt, Melissa C.W., et al.
Publicado: (2018)

Comprehensibility of a personalized medication overview compared to usual-care prescription drug labels
por: Schackmann, Laura, et al.
Publicado: (2022)

Development of an Infrastructure for the Prediction of Biological Endpoints in Industrial Environments. Lessons Learned at the eTOX Project
por: Pastor, Manuel, et al.
Publicado: (2018)

Don't pay for poor quality spirometry tests
por: Enright, Paul, et al.
Publicado: (2013)

Deep Neural Network Models for Predicting Chemically Induced Liver Toxicity Endpoints From Transcriptomic Responses
por: Wang, Hao, et al.
Publicado: (2019)

Importance of achieving the composite endpoints in diabetes
por: Unnikrishnan, Ambika Gopalakrishnan, et al.
Publicado: (2013)

The Importance of Endpoints in Oncology Clinical Trials
por: Faiman, Beth
Publicado: (2023)

Quantitative Systems Pharmacology Model-Based Predictions of Clinical Endpoints to Optimize Warfarin and Rivaroxaban Anti-Thrombosis Therapy
por: Hartmann, Sonja, et al.
Publicado: (2020)

Patient-led development of digital endpoints and the use of computer vision analysis in assessment of motor function in rare diseases
por: Ferrer-Mallol, Elisa, et al.
Publicado: (2022)

Patients’ preferences for selection of endpoints in cardiovascular clinical trials
por: Chow, Robert D., et al.
Publicado: (2014)

Disentangling Rheumatoid Arthritis Patients’ Implicit and Explicit Attitudes toward Methotrexate
por: Linn, Annemiek J., et al.
Publicado: (2016)

Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study
por: Roldan Munoz, Sonia, et al.
Publicado: (2021)

Effects of Telephone Counseling Intervention by Pharmacists (TelCIP) on Medication Adherence; Results of a Cluster Randomized Trial
por: Kooij, Marcel J., et al.
Publicado: (2016)

The Minimal Clinically Important Differences as Well as Statistical Differences of Main Endpoints are Important in Comparing Postoperative Benefits of Different Analgesic Modalities [Letter]
por: Tian, Tian, et al.
Publicado: (2022)

Endpoints in pediatric pain studies
por: van Dijk, Monique, et al.
Publicado: (2010)

The preferences of users of electronic medical records in hospitals: quantifying the relative importance of barriers and facilitators of an innovation
por: Struik, Marjolijn HL, et al.
Publicado: (2014)

Effectiveness of a Patient-Tailored, Pharmacist-Led Intervention Program to Enhance Adherence to Antihypertensive Medication: The CATI Study
por: van der Laan, Danielle M., et al.
Publicado: (2018)

Non-adherence to guideline recommendations for insulins: a qualitative study amongst primary care practitioners
por: Dankers, M., et al.
Publicado: (2022)

URB2 as an important marker for glioma prognosis and immunotherapy
por: Fang, Chaoyou, et al.
Publicado: (2023)

Surrogate Endpoints for Late Kidney Transplantation Failure
por: Naesens, Maarten, et al.
Publicado: (2022)

Comprehensive self management and routine monitoring in chronic obstructive pulmonary disease patients in general practice: randomised controlled trial
por: Bischoff, Erik W M A, et al.
Publicado: (2012)

Patient and Payer Preferences for Additional Value Criteria
por: Jakab, Ivett, et al.
Publicado: (2021)

Pharmacokinetic and pharmacodynamic similarity evaluation between an insulin glargine biosimilar product and Lantus(®) in healthy subjects: Pharmacokinetic parameters of both parent insulin glargine and M1 were used as endpoints
por: Wang, Yiya, et al.
Publicado: (2022)

Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial
por: Rabe, Klaus F., et al.
Publicado: (2020)

Knowledge Claims, Jurisdictional Control and Professional Status: The Case of Nurse Prescribing
por: Kroezen, Marieke, et al.
Publicado: (2013)

How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action
por: Janssens, Rosanne, et al.
Publicado: (2023)

Diagnostic accuracy of pre-bronchodilator FEV(1)/FEV(6) from microspirometry to detect airflow obstruction in primary care: a randomised cross-sectional study
por: van den Bemt, Lisette, et al.
Publicado: (2014)

Editorial: Deprescribing and Minimizing Use of Anticholinergic Medications
por: Soiza, Roy L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9a6uhje57uoaa19kmd9olv50kq